Core Scientific (CORZ) Cash & Current Investments (2021 - 2026)

Core Scientific has disclosed Cash & Current Investments across 6 years of filings, most recently posting $1.1 billion for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $1.1 billion, up 52.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 52.49% YoY), and the FY2025 annual result was $311.4 million, down 62.8% from the prior year.
• Cash & Current Investments came in at $1.1 billion for Q1 2026 at Core Scientific, up from $311.4 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $1.1 billion in Q1 2026 to a low of $37.6 million in Q3 2022.
• The 5-year median for Cash & Current Investments is $140.4 million (2022), against an average of $311.6 million.
• Across the five-year window, Cash & Current Investments jumped 18181.06% in 2022 and tumbled 81.55% in 2023, its largest moves.
• Core Scientific's Cash & Current Investments stood at $52.2 million in 2022, then soared by 33.44% to $69.7 million in 2023, then surged by 1100.68% to $837.0 million in 2024, then slumped by 62.8% to $311.4 million in 2025, then soared by 242.15% to $1.1 billion in 2026.
• The last three Cash & Current Investments figures came in at $1.1 billion (Q1 2026), $311.4 million (Q4 2025), and $453.4 million (Q3 2025), per Business Quant data.